1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by OTC Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global OTC Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Class A
1.4.3 Class B
1.5 Market by Application
1.5.1 Global OTC Drug Market Share by Application: 2021-2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Household
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global OTC Drug Market
1.8.1 Global OTC Drug Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global OTC Drug Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global OTC Drug Revenue Market Share by Manufacturers (2015-2020)
2.3 Global OTC Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers OTC Drug Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global OTC Drug Sales Volume Market Share by Region (2015-2020)
3.2 Global OTC Drug Sales Revenue Market Share by Region (2015-2020)
3.3 North America OTC Drug Sales Volume
3.3.1 North America OTC Drug Sales Volume Growth Rate (2015-2020)
3.3.2 North America OTC Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia OTC Drug Sales Volume
3.4.1 East Asia OTC Drug Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia OTC Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe OTC Drug Sales Volume (2015-2020)
3.5.1 Europe OTC Drug Sales Volume Growth Rate (2015-2020)
3.5.2 Europe OTC Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia OTC Drug Sales Volume (2015-2020)
3.6.1 South Asia OTC Drug Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia OTC Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia OTC Drug Sales Volume (2015-2020)
3.7.1 Southeast Asia OTC Drug Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia OTC Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East OTC Drug Sales Volume (2015-2020)
3.8.1 Middle East OTC Drug Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East OTC Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa OTC Drug Sales Volume (2015-2020)
3.9.1 Africa OTC Drug Sales Volume Growth Rate (2015-2020)
3.9.2 Africa OTC Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania OTC Drug Sales Volume (2015-2020)
3.10.1 Oceania OTC Drug Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania OTC Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America OTC Drug Sales Volume (2015-2020)
3.11.1 South America OTC Drug Sales Volume Growth Rate (2015-2020)
3.11.2 South America OTC Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World OTC Drug Sales Volume (2015-2020)
3.12.1 Rest of the World OTC Drug Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World OTC Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America OTC Drug Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia OTC Drug Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe OTC Drug Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia OTC Drug Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia OTC Drug Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East OTC Drug Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa OTC Drug Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania OTC Drug Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America OTC Drug Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World OTC Drug Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global OTC Drug Sales Volume Market Share by Type (2015-2020)
14.2 Global OTC Drug Sales Revenue Market Share by Type (2015-2020)
14.3 Global OTC Drug Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global OTC Drug Consumption Volume by Application (2015-2020)
15.2 Global OTC Drug Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in OTC Drug Business
16.1 Bayer HealthCare
16.1.1 Bayer HealthCare Company Profile
16.1.2 Bayer HealthCare OTC Drug Product Specification
16.1.3 Bayer HealthCare OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Bristol Myers Squibb
16.2.1 Bristol Myers Squibb Company Profile
16.2.2 Bristol Myers Squibb OTC Drug Product Specification
16.2.3 Bristol Myers Squibb OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Pfizer
16.3.1 Pfizer Company Profile
16.3.2 Pfizer OTC Drug Product Specification
16.3.3 Pfizer OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 GlaxoSmithKline (GSK)
16.4.1 GlaxoSmithKline (GSK) Company Profile
16.4.2 GlaxoSmithKline (GSK) OTC Drug Product Specification
16.4.3 GlaxoSmithKline (GSK) OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 BioGaia
16.5.1 BioGaia Company Profile
16.5.2 BioGaia OTC Drug Product Specification
16.5.3 BioGaia OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Johnson&Johnson
16.6.1 Johnson&Johnson Company Profile
16.6.2 Johnson&Johnson OTC Drug Product Specification
16.6.3 Johnson&Johnson OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Chr. Hansen
16.7.1 Chr. Hansen Company Profile
16.7.2 Chr. Hansen OTC Drug Product Specification
16.7.3 Chr. Hansen OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 AstraZeneca
16.8.1 AstraZeneca Company Profile
16.8.2 AstraZeneca OTC Drug Product Specification
16.8.3 AstraZeneca OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Sanofi
16.9.1 Sanofi Company Profile
16.9.2 Sanofi OTC Drug Product Specification
16.9.3 Sanofi OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Bukwang Pharmaceutica
16.10.1 Bukwang Pharmaceutica Company Profile
16.10.2 Bukwang Pharmaceutica OTC Drug Product Specification
16.10.3 Bukwang Pharmaceutica OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 DSM
16.11.1 DSM Company Profile
16.11.2 DSM OTC Drug Product Specification
16.11.3 DSM OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Herbalife
16.12.1 Herbalife Company Profile
16.12.2 Herbalife OTC Drug Product Specification
16.12.3 Herbalife OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Cipla
16.13.1 Cipla Company Profile
16.13.2 Cipla OTC Drug Product Specification
16.13.3 Cipla OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Eisai
16.14.1 Eisai Company Profile
16.14.2 Eisai OTC Drug Product Specification
16.14.3 Eisai OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Friggs
16.15.1 Friggs Company Profile
16.15.2 Friggs OTC Drug Product Specification
16.15.3 Friggs OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 CoLucid
16.16.1 CoLucid Company Profile
16.16.2 CoLucid OTC Drug Product Specification
16.16.3 CoLucid OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 Euradite
16.17.1 Euradite Company Profile
16.17.2 Euradite OTC Drug Product Specification
16.17.3 Euradite OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.18 Eli Lilly
16.18.1 Eli Lilly Company Profile
16.18.2 Eli Lilly OTC Drug Product Specification
16.18.3 Eli Lilly OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.19 Daiichi Sankyo
16.19.1 Daiichi Sankyo Company Profile
16.19.2 Daiichi Sankyo OTC Drug Product Specification
16.19.3 Daiichi Sankyo OTC Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 OTC Drug Manufacturing Cost Analysis
17.1 OTC Drug Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of OTC Drug
17.4 OTC Drug Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 OTC Drug Distributors List
18.3 OTC Drug Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of OTC Drug (2021-2026)
20.2 Global Forecasted Revenue of OTC Drug (2021-2026)
20.3 Global Forecasted Price of OTC Drug (2015-2026)
20.4 Global Forecasted Production of OTC Drug by Region (2021-2026)
20.4.1 North America OTC Drug Production, Revenue Forecast (2021-2026)
20.4.2 East Asia OTC Drug Production, Revenue Forecast (2021-2026)
20.4.3 Europe OTC Drug Production, Revenue Forecast (2021-2026)
20.4.4 South Asia OTC Drug Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia OTC Drug Production, Revenue Forecast (2021-2026)
20.4.6 Middle East OTC Drug Production, Revenue Forecast (2021-2026)
20.4.7 Africa OTC Drug Production, Revenue Forecast (2021-2026)
20.4.8 Oceania OTC Drug Production, Revenue Forecast (2021-2026)
20.4.9 South America OTC Drug Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World OTC Drug Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of OTC Drug by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of OTC Drug by Country
21.2 East Asia Market Forecasted Consumption of OTC Drug by Country
21.3 Europe Market Forecasted Consumption of OTC Drug by Countriy
21.4 South Asia Forecasted Consumption of OTC Drug by Country
21.5 Southeast Asia Forecasted Consumption of OTC Drug by Country
21.6 Middle East Forecasted Consumption of OTC Drug by Country
21.7 Africa Forecasted Consumption of OTC Drug by Country
21.8 Oceania Forecasted Consumption of OTC Drug by Country
21.9 South America Forecasted Consumption of OTC Drug by Country
21.10 Rest of the world Forecasted Consumption of OTC Drug by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer